查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434877

苯磺酸氨氯地平市场：按类型、按应用分类 - 全球预测 2024-2030

Amlodipine Besylate Market by Type (10 mg Tablets, 2.5 mg Tablets, 5 mg Tablets), Application (Heart Diseases, High Blood Pressure) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

苯磺酸氨氯地平市场规模预估2023年为41,337万美元，2024年达4,3728万美元，预估2030年将达6,2905万美元，复合年增长率为6.18%。

苯磺酸氨氯地平全球市场

主要市场统计
基准年[2023] 41337万美元
预测年份 [2024] 43728万美元
预测年份 [2030] 62905万美元
复合年增长率（%） 6.18%
苯磺酸氨氯地平市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估苯磺酸氨氯地平市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对苯磺酸氨氯地平市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

苯磺酸1-氨氯地平市场的市场规模和预测是多少？

在2-苯磺酸氨氯地平市场预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-苯磺酸氨氯地平市场的技术趋势和法律规范是什么？

4-苯磺酸氨氯地平市场主要供应商的市场占有率是多少？

进入苯磺酸5-氨氯地平市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 高血压和心臟病盛行率上升
      • 苯磺酸氨氯地平在各种治疗的使用增加
      • 冠心病治疗指出的实施
    • 抑制因素
      • 氨氯地平替代品的可用性
    • 机会
      • 新引入快速测试和照护现场诊断
      • 增加对苯磺酸氨氯地平研发活动的投资
    • 任务
      • 关于苯磺酸氨氯地平副作用的担忧
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章苯磺酸氨氯地平市场：依类型

  • 10毫克片剂
  • 2.5毫克片剂
  • 5毫克片剂

第七章苯磺酸氨氯地平市场：依应用分类

  • 心臟疾病
  • 高血压

第八章 苯磺酸氨氯地平北美、南美市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区苯磺酸氨氯地平市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲苯磺酸氨氯地平市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • Apotex Inc.
    • Aurobindo Pharma Limited
    • Cadila Pharmaceuticals Limited
    • Century Pharmaceuticals Ltd.
    • Changzhou Yabang Pharmaceutical Co., Ltd.
    • Chartwell Pharmaceuticals LLC
    • Cipla Inc.
    • Dr. Reddys Laboratories Ltd.
    • Lupin Limited
    • MOEHS IBERICA, SL
    • Orbion Pharmaceuticals Private Limited
    • Pfizer Inc.
    • Sanofi SA
    • Strides Pharma Science Limited
    • Teva Pharmaceutical Industries Ltd.
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-742BD517AB12

[196 Pages Report] The Amlodipine Besylate Market size was estimated at USD 413.37 million in 2023 and expected to reach USD 437.28 million in 2024, at a CAGR 6.18% to reach USD 629.05 million by 2030.

Global Amlodipine Besylate Market

KEY MARKET STATISTICS
Base Year [2023] USD 413.37 million
Estimated Year [2024] USD 437.28 million
Forecast Year [2030] USD 629.05 million
CAGR (%) 6.18%
Amlodipine Besylate Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Amlodipine Besylate Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Amlodipine Besylate Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Amlodipine Besylate Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Aurobindo Pharma Limited, Cadila Pharmaceuticals Limited, Century Pharmaceuticals Ltd., Changzhou Yabang Pharmaceutical Co., Ltd., Chartwell Pharmaceuticals LLC, Cipla Inc., Dr. Reddys Laboratories Ltd., Lupin Limited, MOEHS IBERICA, SL, Orbion Pharmaceuticals Private Limited, Pfizer Inc., Sanofi S.A., Strides Pharma Science Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Amlodipine Besylate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • 10 mg Tablets
    • 2.5 mg Tablets
    • 5 mg Tablets
  • Application
    • Heart Diseases
    • High Blood Pressure
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Amlodipine Besylate Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Amlodipine Besylate Market?

3. What are the technology trends and regulatory frameworks in the Amlodipine Besylate Market?

4. What is the market share of the leading vendors in the Amlodipine Besylate Market?

5. Which modes and strategic moves are suitable for entering the Amlodipine Besylate Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Amlodipine Besylate Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of hypertension and heart diseases
      • 5.1.1.2. Increasing usage of amlodipine besylate in various treatments
      • 5.1.1.3. Implementation of guidelines for coronary artery disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative medications to amlodipine
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging adoption of rapid testing and point-of-care diagnosis
      • 5.1.3.2. Increasing investments in research and development activities of amlodipine besylate
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with side effects of amlodipine besylate
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Amlodipine Besylate Market, by Type

  • 6.1. Introduction
  • 6.2. 10 mg Tablets
  • 6.3. 2.5 mg Tablets
  • 6.4. 5 mg Tablets

7. Amlodipine Besylate Market, by Application

  • 7.1. Introduction
  • 7.2. Heart Diseases
  • 7.3. High Blood Pressure

8. Americas Amlodipine Besylate Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Amlodipine Besylate Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Amlodipine Besylate Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Apotex Inc.
    • 12.1.2. Aurobindo Pharma Limited
    • 12.1.3. Cadila Pharmaceuticals Limited
    • 12.1.4. Century Pharmaceuticals Ltd.
    • 12.1.5. Changzhou Yabang Pharmaceutical Co., Ltd.
    • 12.1.6. Chartwell Pharmaceuticals LLC
    • 12.1.7. Cipla Inc.
    • 12.1.8. Dr. Reddys Laboratories Ltd.
    • 12.1.9. Lupin Limited
    • 12.1.10. MOEHS IBERICA, SL
    • 12.1.11. Orbion Pharmaceuticals Private Limited
    • 12.1.12. Pfizer Inc.
    • 12.1.13. Sanofi S.A.
    • 12.1.14. Strides Pharma Science Limited
    • 12.1.15. Teva Pharmaceutical Industries Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AMLODIPINE BESYLATE MARKET RESEARCH PROCESS
  • FIGURE 2. AMLODIPINE BESYLATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AMLODIPINE BESYLATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AMLODIPINE BESYLATE MARKET DYNAMICS
  • FIGURE 7. AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMLODIPINE BESYLATE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. AMLODIPINE BESYLATE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AMLODIPINE BESYLATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AMLODIPINE BESYLATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. AMLODIPINE BESYLATE MARKET SIZE, BY 10 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AMLODIPINE BESYLATE MARKET SIZE, BY 2.5 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AMLODIPINE BESYLATE MARKET SIZE, BY 5 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. AMLODIPINE BESYLATE MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMLODIPINE BESYLATE MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. AMLODIPINE BESYLATE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. AMLODIPINE BESYLATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. AMLODIPINE BESYLATE MARKET LICENSE & PRICING